The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Theofan Georgia since year 2005.
The trader's CIK number is 1280158.
At the time of this reporting, Theofan Georgia is the VP, Clinical Develop of Immune Response Corp .
(stock ticker symbol IMNR).
See this page for all insider trading activities at Immune Response Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2006-09-15||OCHT||Immune Response Corp||Sale||150,000||2.00||300,000|
|2006-08-31||OCHT||Immune Response Corp||Sale||200,000||2.00||400,000|
|2006-08-29||OCHT||Immune Response Corp||Sale||250,000||2.00||500,000|
|2006-08-25||OCHT||Immune Response Corp||Sale||250,000||2.00||500,000|
|2006-09-08||OCHT||Immune Response Corp||Sale||2,180,000||2.00||4,360,000|
|2006-10-19||OCHT||Immune Response Corp||Sale||720,000||2.00||1,440,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Theofan Georgia (VP, Clinical Develop of Immune Response Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.